Oncoplastic breast-conserving surgery utilization among eligible premenopausal women: A quality-care review at a tertiary academic center.
Abstract
403 Background: For early-stage breast cancer, mastectomy and breast-conserving surgery (BCS) with radiation provide equivalent survival, but tumor-to-breast size often limits BCS eligibility. Oncoplastic BCS (OBCS) expands candidacy through volume-replacement techniques that prevent large lumpectomy defects. Despite this, OBCS use remains low, particularly among premenopausal patients. To inform strategies to improve utilization, we examined practice patterns of OBCS at a tertiary academic center. Methods: This retrospective review queried premenopausal women with DCIS or unifocal, noninflammatory invasive breast cancer who underwent surgery from 1/1/2024–12/31/2025. Eligibility required tumors >1–5 cm in quadrants amenable to volume-replacement OBCS, BMI 20–35 kg/m², no pathogenic variant, prior radiation, or contraindications to flap healing. Post-neoadjuvant imaging was used to reassess borderline cases. Fisher’s exact and Mann-Whitney U tests compared characteristics between OBCS-eligible patients undergoing OBCS and mastectomy. Results: Thirty-eight premenopausal patients met OBCS criteria. Among them, 22 (58%) had cT1c and 16 (42%) had cT2 disease; 15 (39%) had palpable tumors. Sixteen (42%) received neoadjuvant therapy (NAC). Only six (16%) underwent OBCS (five reduction mammoplasties, one level I/II rearrangement), while 11 (28.9%) had lumpectomy without documented OBCS closure and 21 (55.3%) elected mastectomy. Of the 21 choosing mastectomy, 14 (66.7%) preferred bilateral/prophylactic mastectomy. One patient predetermined her choice and declined discussion of BCS alternatives. Groups were similar across most characteristics, though mastectomy patients trended toward larger tumors (p=0.05). Conclusions: In this modern cohort of OBCS-eligible patients, mastectomy remained the dominant choice. Although drivers of limited use of BCS approaches are not fully defined, larger tumors may continue to influence selection of mastectomy despite available OBCS techniques. These findings highlight a quality-of-care opportunity to strengthen patient education and shared decision-making around BCS options that preserve cosmesis. Patient characteristics by surgical procedure. Characteristic BCS (N=17) Mastectomy (N=21) p-value Age at Dx, median (IQR) 45 (42–47) 42 (37–45) 0.53 BMI, median (IQR) 27.6 (22.2–29.5) 25.9 (23.2–29.8) 0.93 White 11 (65%) 18 (85.7%) Black 2 (12%) 1 (4.8%) Asian 3 (18%) — Other 1 (6%) — Palpable presentation 8 (47%) 7 (33%) 0.51 NAC Therapy 5 (29%) 11 (52%) 0.20 Tumor size (cm), median (IQR) 1.70 (1.40–2.10) 2.10 (1.80–2.90) 0.05